Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Pharmacology and Therapeutics|July 20, 2018
Dose-ranging study of an orlistat tablet formulationSusan M Schwartz, David M Savastano
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 19, 2005
Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intakeDavid M Savastano, Melissa Carelle, Mihai Covasa
The Journal of Nutrition|July 2, 2010
Reduced sensitivity to cholecystokinin in male rats fed a high-fat diet is reversibleTimothy D Swartz, David M Savastano, Mihai Covasa
Physiology & Behavior|August 26, 2004
Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptorsMatthew R Hayes, David M Savastano, Mihai Covasa
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 18, 2006
Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrainDavid M Savastano, Matthew R Hayes, Mihai Covasa
Clinical Pharmacology in Drug Development|April 17, 2018
Pharmacologic and Pharmacodynamic Equivalence of 2 Formulations of OrlistatSteven Johnson, Susan M Schwartz
International Journal of Clinical Pharmacology and Therapeutics|May 18, 2017
Actual use of and adherence to ibuprofen 400 mg tablet dosing instructions in a simulated OTC environment
Suzanne Meeves, Rina Leyva, Clark Richardson, et al.
Pageof 3